Amazon Original Series Regular Heroes to Premiere May 8 Highlighting Courageous Stories From the Front-Lines of COVID-19
Regular Heroes is an eight-episode docuseries highlighting the contributions and personal sacrifices of just some of today’s most generous individuals who are going above and beyond to support their communities during the COVID-19 crisis. The series premieres on Amazon Prime Video in the U.S., U.K., Canada and Australia on Friday, May 8. In addition to shining the spotlight on the heroes’ tireless work and amplifying their efforts in cities including New York City, Los Angeles, New Orleans, Chicago, and Seattle among others, the series will offer support and assistance with donations of goods, services and more so that they can continue to pay it forward and help their communities. New episodes of Regular Heroes will be available every Friday. The series will premiere in all other Amazon Prime Video territories May 12, 2020.
In the premiere episode of Regular Heroes, Native New Yorker and 15-time Grammy Award-winning singer, producer and author Alicia Keys will help shine a light on Trevor Henry, Burnell Cotlon and Athena Hayley as they each make personal sacrifices for their families and communities. Additionally, Keys’ moving new song, “Good Job,” will be featured in the series. Subsequent episodes with additional talent and heroes will be announced at a later date.
“This show is Amazzziinngg!!! So pure and genuine! I’m happy to know this series will not only give support to but also put a face on the incredible people like Trevor, Burnell and Hayley. They are the ones we clap for each night at 7pm in New York. These are the Heroes. And I’m so honored to celebrate them!!” said Keys.
“We are so proud to celebrate people who are doing so much to transform the lives of people in their communities. This show is inspired by the individuals who give so much to others every day of the year but even more so during this challenging time. They are true role models and we can’t wait to share their stories with Prime Video customers everywhere,” said Jennifer Salke, Head of Amazon Studios.
Episode One (May 8, 2020): “A New Type Of Hero” with a special appearance by Alicia Keys. Featuring:
TREVOR HENRY (NEW YORK CITY)
Trevor Henry, born and raised in the Bronx, is a husband and father of four who works as a Senior Inventory Specialist at HSS (Hospital for Special Surgery). He spends his 10-hour days supporting doctors and nurses as they tend to the sickest COVID-19 patients in the unit. When Trevor isn’t at the hospital, he’s helping his children with their schoolwork as he swaps shifts with his wife who also is an essential worker at a different hospital in New York.
BURNELL COTLON (NEW ORLEANS)
For the last 10 years, Burnell Cotlon has been a staple in New Orleans’ Lower 9th Ward. After Hurricane Katrina wiped out all viable businesses in the town, Burnell invested his life savings into building a grocery store – “Burnell’s 9th Ward Grocery.” As the only grocery store within a 5-mile radius, Burnell continues to service his customers who have been struck with massive layoffs, including donating food to those in need. His life mission is to get the Lower 9th Ward back on par with the rest of New Orleans.
ATHENA HAYLEY (LOS ANGELES)
After overcoming homelessness, Athena Hayley, who goes by her last name, set out on a mission to help others who found themselves in a similar situation. Never one to give up, once she was off the streets, Hayley rented out the living room of her apartment, just so she could make ends meet and put aside some money to start the “Love My Neighbor Foundation.” For the last five years, Hayley has served as a family figure to the residents at the infamous Skid Row, and through her organization, she helps feed and clothe those in need.
Regular Heroes will feature people making a difference in their cities and communities from all walks of life: Health care and emergency workers, grocery store employees, farmers, bus drivers, delivery personnel, sanitation workers, police officers, and others. If you or someone you know is making an extraordinary difference in their community please visit Regular-Heroes.com to apply.
Regular Heroes is produced by Amazon Studios in association with Philymack, TyTy & Jay Brown Productions and MGM’s Big Fish Entertainment. Philip McIntyre, John Lloyd Taylor, Laurence “Jay” Brown, Tyran “Ty Ty” Smith, Dan Cesareo, Lucilla D’Agostino and Jordana Starr serve as Executive Producers.
About Prime Video
Prime Video offers customers a vast collection of digital videos—all available to watch on practically any device.
- Included with Prime Video: Watch tons of popular movies and TV shows, award-winning Amazon Originals and other exclusives, sports, and more. Think Emmy Award winners Fleabag and The Marvelous Mrs. Maisel, Tom Clancy’s Jack Ryan, Mindy Kaling’s Late Night, Donald Glover’s Guava Island, Academy Award-nominated The Big Sick, Troop Zero, The Boys, Homecoming, Thursday Night Football and licensed and self-published content. Prime Video is available in more than 240 countries and territories worldwide (offers and titles vary based on location).
- Prime Video Channels: Prime members can add channels like HBO, Cinemax, STARZ, SHOWTIME, CBS All Access, NBA League Pass and MLB.tv —no extra apps to download, and no cable required. Only pay for the ones you want, and cancel anytime. View the full list of channels available at amazon.com/channels.
- Rent or Buy: Enjoy new-release movies to rent or buy, entire seasons of current TV shows available to buy, with special deals just for Prime members.
- Instant access: Watch at home or on the go with your choice of hundreds of compatible devices. Stream from the web or using the Prime Video app on your smartphone, tablet, set-top box, game console, or select smart tv. For a complete list of compatible devices, visit amazon.com/howtostream.
- Enhanced experiences: Make the most of every viewing with 4K Ultra HD- and High Dynamic Range (HDR)-compatible content. Go behind the scenes of your favorite movies and TV shows with exclusive X-Ray access, powered by IMDb. Save it for later with select mobile downloads for offline viewing.
Prime Video is just one of many benefits included with a Prime membership, along with fast free shipping on millions of items at Amazon.com, unlimited photo storage, exclusive deals and discounts, and access to ad-free music and Kindle ebooks. To sign-up or start a free trial of Amazon Prime visit: amazon.com/prime.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200507005887/en/
Contact information
PUBLICITY CONTACTS:
For Amazon Studios:
Kristen Hall
Kristen.Hall@AmazonStudios.com
For Philymack:
Alexis Rasten
Alexis@Philymack.com
For Big Fish Entertainment:
Leslie Oren, Babygrande PR
leslie@babygrandepr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
